More importantly, VEGFR1 and VEGFR2 were expressed on tumor cells in schwannomas in NF2 patients (Fig. 3c), suggesting that NF2 schwannomas themselves can be direct targets of VEGFRs vaccination. The gene discussed is FLT1; the disease is neoplasm.